bioAffinity Technologies, Inc. (BIAF)
1.71
+0.05
(+3.01%)
USD |
NASDAQ |
Dec 10, 16:00
1.67
-0.04
(-2.34%)
After-Hours: 20:00
bioAffinity Technologies Total Liabilities (Quarterly): 2.644M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| FONAR Corp. | 56.96M |
| XWELL, Inc. | 18.68M |
| ProPhase Labs, Inc. | 58.84M |
| Veracyte, Inc. | 110.12M |
| Insight Molecular Diagnostics, Inc. | 53.13M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.55M |
| Shareholders Equity (Quarterly) | 8.902M |
| Debt to Equity Ratio | 0.0765 |
| Current Ratio | 3.650 |
| Net Debt Paydown Yield | 1.36% |